Prognostic value of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) in patients with RAS-mutant metastatic colorectal cancer

BackgroundPatients with metastatic colorectal cancer (mCRC) generally have a poor prognosis, and treatment strategies are highly dependent on the RAS mutational status. During disease progression, patients often exhibit dynamic changes in serum lipid profiles. However, the prognostic significance of...

Full description

Bibliographic Details

Published in:	Frontiers in Nutrition
Main Authors:	Wenxia Xie, Huizhuo Liu, Yunjiao Shi, Bingxin Zhang, Ruoyun Wang, Shayan Wang, Bin Liang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	metastatic colorectal cancer Non-HDL-C/HDL-C NHHR prognosis RAS-mutant
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2025.1617930/full